St. Jude Medical (STJ) 38.84 -1.06

St. Jude Medical, Inc.
(STJ) 38.84 -1.06

Last Trade:	38.54	Day Range:	38.50 - 39.24
Trade Time:	06:05PM	52wk Range:	32.13 - 49.90
Prev. Close:	39.60	Market Cap:	12.09B
Open:	39.21	Div Yield:	2.23
Volume:	1910800	PE:	160
EPS:	2.47

The Latest On STJ

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings 5/15/12 9:17am

From Earlier: St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension 5/15/12 7:25am

UPDATE: Citigroup Reiterates Sell Rating, Lowers PT for St. Jude Medical 5/14/12 11:51am

Benzinga's Top Upgrades 5/14/12 7:40am

A Peek Into The Market Before The Trading Starts 5/14/12 7:30am

Financial Breakfast: Morning News Summary for May 14, 2012 5/14/12 7:25am

UPDATE: Goldman Sachs Upgrades St. Jude Medical; Raises PT 5/14/12 7:19am

St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up Study; Confirms ICD Therapy Improves Long-Term Survival of Patients with Heart Failure 5/10/12 4:21pm

Benzinga's Top Upgrades with Color for May 9, 2012 5/9/12 9:58am

UPDATE: Morgan Stanley Upgrades St. Jude Medical; Establishes PT 5/9/12 9:43am

St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired Shape 5/9/12 8:05am

St. Jude Medical Announces FDA Approval of Smaller ICD 5/9/12 8:04am

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings 5/15/12

From Earlier: St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension 5/15/12

UPDATE: Citigroup Reiterates Sell Rating, Lowers PT for St. Jude Medical 5/14/12

Benzinga's Top Upgrades 5/14/12

A Peek Into The Market Before The Trading Starts 5/14/12

Financial Breakfast: Morning News Summary for May 14, 2012 5/14/12

UPDATE: Goldman Sachs Upgrades St. Jude Medical; Raises PT 5/14/12

St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up Study; Confirms ICD Therapy Improves Long-Term Survival of Patients with Heart Failure 5/10/12

Benzinga's Top Upgrades with Color for May 9, 2012 5/9/12

UPDATE: Morgan Stanley Upgrades St. Jude Medical; Establishes PT 5/9/12

St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired Shape 5/9/12

St. Jude Medical Announces FDA Approval of Smaller ICD 5/9/12

Financial Breakfast: Morning News Summary for May 14, 2012 5/14/12

Earnings Expectations for the Week of April 16 (GS, MSFT, MCD) 4/15/12

Top 4 Large-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest ROA 4/12/12

St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now 3/21/12

Top Performing Health Care Stocks in January 2/1/12

Earnings Expectations for the Week of January 23 1/22/12

Financial Breakfast: Morning News Summary for December 13, 2011 12/13/11

Citi Rates St. Jude Medical Sell With $34 PT 12/9/11

Collins Stewart Rates St. Jude Medical Buy With $52 PT 11/30/11

Top 4 Large-Cap Stocks In The Medical Appliances & Equipment Industry With The Lowest PEG Ratio 10/28/11

Bacon & Trades: Morning News Summary for October 19, 2011 10/19/11

Earnings Expectations for the Week of October 17 10/16/11

UPDATE: Citigroup Reiterates Sell Rating, Lowers PT for St. Jude Medical 5/14/12

Benzinga's Top Upgrades 5/14/12

Financial Breakfast: Morning News Summary for May 14, 2012 5/14/12

UPDATE: Goldman Sachs Upgrades St. Jude Medical; Raises PT 5/14/12

Benzinga's Top Upgrades with Color for May 9, 2012 5/9/12

UPDATE: Morgan Stanley Upgrades St. Jude Medical; Establishes PT 5/9/12

Morgan Stanley Does Not See Negatives for St. Jude Medical's Durata 4/4/12

UPDATE: Credit Suisse Raises PT on St. Jude Medical to $49 3/27/12

Piper Jaffray: St. Jude's Growth to Accelerate 2/6/12

Morgan Keegan Releases St. Jude Medical Riata Lead Issue Update 1/30/12

UPDATE: Goldman Sachs Raises Target to $40 on St Jude Medical 1/26/12

Canaccord Upgrades St. Jude Medical to Buy 1/26/12

Trade STJ
NOW!

Partner Headlines

Health Care Sector Wrap 5/30/12

MDT Resolute for Diabetic Patients - Analyst Blog 5/30/12

St. Jude Remains Neutral - Analyst Blog 5/25/12

Medtronic Posts Mixed Numbers - Analyst Blog 5/22/12

FDA Approval for BSX Epic Stent - Analyst Blog 5/18/12

BSX Unveils Positive Data at EuroPCR - Analyst Blog 5/16/12

CE Mark for St. Jude's EnligHTN - Analyst Blog 5/16/12

Boston Scientific Innova Has CE Mark - Analyst Blog 5/15/12

Upgrades & Downgrades 5/14/12

The Zacks Analyst Blog Highlights: Bed Bath & Beyond, Cost Plus, Target, Wal-Mart and St. Jude Medical - Press Releases 5/11/12

St. Jude Wins Approval for Ellipse - Analyst Blog 5/10/12

Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio 5/3/12

Press Releases

Key Clinical Data for St. Jude Medical's Structural Heart Technologies Revealed at EuroPCR 5/16/12 Business Wire

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure 5/16/12 Business Wire

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings 5/15/12 Business Wire

St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension 5/15/12 Business Wire

St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up Study 5/10/12 Business Wire

Critical Alerts For JP Morgan, CA Technologies, St Jude Medical, Bed Bath & Beyond, and Sina Corp. Released By InvestorsObserver 5/10/12 Newswire

St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired Shape 5/9/12 Business Wire

St. Jude Medical Announces FDA Approval of Assura™ Implantable Defibrillators with Features That Reduce Inappropriate Shocks 5/8/12 Business Wire

St. Jude Medical to Present at the Bank of America Merrill Lynch 2012 Health Care Conference 5/4/12 Business Wire

Kensey Nash Reports Third Quarter Fiscal Year 2012 Financial Results 5/3/12 Newswire

St. Jude Medical Announces Second Quarter Dividend 5/2/12 Business Wire

St. Jude Medical Updates Optim Lead Registry Data and Status of Riata Leads Study in Bi-Annual Product Performance Report 5/1/12 Business Wire

Get the latest STJ stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for St. Jude Medical, Inc. stock price.

St. Jude Medical, Inc. by YCharts

St. Jude Medical (STJ) 38.84 -1.06

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On STJ

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social